Tango Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX), a biotechnology company focused on advanced cancer treatments, announced key investor conference appearances in March 2023. CEO Barbara Weber will participate in the Cowen 43rd Annual Health Care Conference on March 8 at 11:10 AM ET in Boston, and the Barclays Global Healthcare Conference on March 14 at 3:35 PM ET in Miami. Live webcasts of these presentations will be accessible on their website, with replays available for 90 days post-event. Tango Therapeutics aims to leverage synthetic lethality to develop innovative cancer therapies targeting tumor suppressor gene loss.

BOSTON, March 01, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the following upcoming investor conferences in March.

Cowen 43^rd Annual Health Care Conference
Date: Wednesday, March 8, 2023
Time: 11:10 AM ET
Location: Boston, MA

Barclays Global Healthcare Conference
Date: Tuesday, March 14, 2023
Time: 3:35 PM ET
Location: Miami, FL

A live webcast of the presentations will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcasts will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

Investor Contact:
Sam Martin/Andrew Vulis
Argot Partners
tango@argotpartners.com

Media Contact:
Joshua R. Mansbach
Argot Partners
tango@argotpartners.com

FAQ

What is the schedule for Tango Therapeutics at the Cowen 43rd Annual Health Care Conference?

Tango Therapeutics will present on March 8, 2023, at 11:10 AM ET in Boston.

When will Barbara Weber speak at the Barclays Global Healthcare Conference?

Barbara Weber will speak on March 14, 2023, at 3:35 PM ET in Miami.

Where can I watch the presentations from Tango Therapeutics' investor conferences?

The presentations will be available via live webcast under the 'Events & Presentations' tab on Tango Therapeutics' website.

What is the focus of Tango Therapeutics' research?

Tango Therapeutics focuses on discovering precision cancer medicines utilizing synthetic lethality.

What is the potential impact of Tango Therapeutics' therapies?

Their therapies aim to target critical areas like tumor suppressor gene loss, enhancing treatment for cancer patients.